News

Thermo Fisher Scientific today completed its previously announced acquisition of Finesse Solutions.

Genetically engineered HPV genomes enable identification of potential drug targets and candidates

Researchers use patients-derived stem cells to make blood progenitor cells and screen for treatment of Diamond-Blackfan Anemia.

Human gene editing is not new, but with the emergence of technologies like CRISPR–Cas9 experts agreed in 2015 that a broad framework was needed to better understand the science and its implications for policy, ethics and society.

Salk team develops tool that maps functional areas of the genome to better understand disease.

The collaboration will aim to advance clinical pharmacogenomics.

Insights may lead to ways to predict whether a tumor will respond to immunotherapy.

Columbia researchers identify transcriptional profile of motor neurons innervating digit muscles.

Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.

A new study shows how errors in a specific gene can cause growth defects associated with a rare type of dwarfism.